Last reviewed · How we verify
NCT06270966
Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT
NA trial testing Virtual Reality Cognitive Remediation in Mild Cognitive Impairment in 30 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | University of Cagliari |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 7 March 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Virtual Reality Cognitive Remediation
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Cognitive Remediation — all drugs for Cognitive Remediation →
- Virtual Reality — all drugs for Virtual Reality →
- Psychiatric Rehabilitation — all drugs for Psychiatric Rehabilitation →
Sponsor
University of Cagliari
Who can join
65 and older, any sex, with Mild Cognitive Impairment or Cognitive Remediation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The need to promote research in active aging trough multidisciplinary and innovative approaches is strongly indicated by the European Union. Our study aims to assess the feasibility and provide a preliminary measure of effectiveness for an intervention using immersive virtual reality (VR) technology for cognitive remediation (CR) in individuals with Mild Cognitive Impairment (MCI)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Virtual reality cognitive remediation tool for individuals with mild cognitive impairment: study protocol for a feasibility randomized clinical trial.
Perra A, Primavera D, Leonetti V, Montisci R, et al · · 2024 · PMID 39651467 · DOI 10.3389/fpubh.2024.1477279
Verify or expand the search:
- PubMed search for NCT06270966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other University of Cagliari trials
Trials by the same sponsor.
- NCT06872151 — Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Per · Phase 4 · completed
- NCT06523920 — Protecting Autologous Free Flaps From Ischemia/Reperfusion Damage With Cold Storage. · NA · not yet recruiting
- NCT06484205 — Evaluation of the Effectiveness of the World Health Organization QualityRights Training in Italy · NA · recruiting
- NCT06526962 — 5Fr Bipolar Electrode vs. Conical Optical 5Fr Fibers for Dual Wave-length Diode Laser for Hysteroscopic Polypectomy · recruiting
- NCT06579378 — Feasibility Study of Virtual Sail 3D in Cognitive Functions · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06270966 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cagliari
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing